{"abstract":"The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Vaccines and Related Biological Products Advisory Committee (the Committee). The general function of the Committee is to provide advice and recommendations to FDA on regulatory issues. The meeting will be open to the public. FDA is establishing a docket for public comment on this document.","action":"Notice; establishment of a public docket; request for comments.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2026/04/27/2026-08122.html","cfr_references":[],"citation":"91 FR 22542","comment_url":null,"comments_close_on":null,"correction_of":null,"corrections":[],"dates":"The meeting will be held on May 28, 2026, from 8:30 a.m. to 4:30 p.m. Eastern Time.","disposition_notes":null,"docket_ids":["Docket No. FDA-2026-N-3962"],"dockets":[],"document_number":"2026-08122","effective_on":null,"end_page":22543,"executive_order_notes":null,"executive_order_number":null,"explanation":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2026/04/27/2026-08122.xml","html_url":"https://www.federalregister.gov/documents/2026/04/27/2026-08122/vaccines-and-related-biological-products-advisory-committee-notice-of-meeting-establishment-of-a","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2026-08122?publication_date=2026-04-27","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2026-04-27/2026-08122/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":18,"last_updated":"2026-04-25 08:15:03 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-04-27/pdf/2026-08122.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":null,"publication_date":"2026-04-27","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2026/04/27/2026-08122.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":22542,"subtype":null,"title":"Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-United States (U.S.) 2026-2027 Formula for COVID-19 Vaccine Composition","toc_doc":"Vaccines and Related Biological Products Advisory Committee; U.S. 20262027 Formula for COVID19 Vaccine Composition","toc_subject":"Hearings, Meetings, Proceedings, etc.","topics":[],"type":"Notice","volume":91}